Cargando…

Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection

BACKGROUND: Herpes simplex virus infection (HSV) is a common and ubiquitous infection of the skin which causes mucocutaneous lesions called cold sores (herpes labialis) or fever blisters. It is estimated that approximately 80% of the population worldwide are carriers of the Herpes simplex virus, app...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasler-Nguyen, Nathalie, Shelton, Donald, Ponard, Gilbert, Bader, Marlene, Schaffrik, Martina, Mallefet, Pascal
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675515/
https://www.ncbi.nlm.nih.gov/pubmed/19341466
http://dx.doi.org/10.1186/1471-5945-9-3
_version_ 1782166705400709120
author Hasler-Nguyen, Nathalie
Shelton, Donald
Ponard, Gilbert
Bader, Marlene
Schaffrik, Martina
Mallefet, Pascal
author_facet Hasler-Nguyen, Nathalie
Shelton, Donald
Ponard, Gilbert
Bader, Marlene
Schaffrik, Martina
Mallefet, Pascal
author_sort Hasler-Nguyen, Nathalie
collection PubMed
description BACKGROUND: Herpes simplex virus infection (HSV) is a common and ubiquitous infection of the skin which causes mucocutaneous lesions called cold sores (herpes labialis) or fever blisters. It is estimated that approximately 80% of the population worldwide are carriers of the Herpes simplex virus, approximately 40% suffer from recurrent recurrent infections. This study evaluates the in vitro skin permeation and penetration of penciclovir and acyclovir from commercialized creams for the treatment of herpes labialis (cold sores), using non viable excised human abdominal skin samples, which were exposed to 5 mg/cm(2 )of acyclovir 5% cream or penciclovir 1% cream. METHODS: After 24 h of cream application, excess cream was washed off and layers of stratum corneum were removed by successive tape stripping. Amounts of active ingredients having penetrated through the skin were measured, as well as the amounts in the washed-off cream, in skin strips and creams remaining in the skin. Molecular modelling was used to evaluate physico-chemical differences between the drugs. Western blot analysis enabled to determine whether the marker of basal cells keratin 5 could be detected in the various tape strips. RESULTS: Application of penciclovir 1% cream yielded higher concentration of drug in the deeper layers of the epidermis as well as a higher drug flux through the skin. Molecular modelling showed two higher hydrophobic moieties for acyclovir. Presence of the basal cell marker keratin 5 was underscored in the deeper tape strips from the skin, giving evidence that both drugs can reach their target cells. CONCLUSION: Penciclovir 1% cream has the tendency to facilitate the diffusion of the drug through the stratum corneum into the deeper epidermis layers, in which it could reach the target basal cells at effective therapeutical concentration. The small difference in the surface properties between both molecules might also contribute to favour the passage of penciclovir through the epidermis into the deeper basal cells.
format Text
id pubmed-2675515
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26755152009-04-30 Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection Hasler-Nguyen, Nathalie Shelton, Donald Ponard, Gilbert Bader, Marlene Schaffrik, Martina Mallefet, Pascal BMC Dermatol Research Article BACKGROUND: Herpes simplex virus infection (HSV) is a common and ubiquitous infection of the skin which causes mucocutaneous lesions called cold sores (herpes labialis) or fever blisters. It is estimated that approximately 80% of the population worldwide are carriers of the Herpes simplex virus, approximately 40% suffer from recurrent recurrent infections. This study evaluates the in vitro skin permeation and penetration of penciclovir and acyclovir from commercialized creams for the treatment of herpes labialis (cold sores), using non viable excised human abdominal skin samples, which were exposed to 5 mg/cm(2 )of acyclovir 5% cream or penciclovir 1% cream. METHODS: After 24 h of cream application, excess cream was washed off and layers of stratum corneum were removed by successive tape stripping. Amounts of active ingredients having penetrated through the skin were measured, as well as the amounts in the washed-off cream, in skin strips and creams remaining in the skin. Molecular modelling was used to evaluate physico-chemical differences between the drugs. Western blot analysis enabled to determine whether the marker of basal cells keratin 5 could be detected in the various tape strips. RESULTS: Application of penciclovir 1% cream yielded higher concentration of drug in the deeper layers of the epidermis as well as a higher drug flux through the skin. Molecular modelling showed two higher hydrophobic moieties for acyclovir. Presence of the basal cell marker keratin 5 was underscored in the deeper tape strips from the skin, giving evidence that both drugs can reach their target cells. CONCLUSION: Penciclovir 1% cream has the tendency to facilitate the diffusion of the drug through the stratum corneum into the deeper epidermis layers, in which it could reach the target basal cells at effective therapeutical concentration. The small difference in the surface properties between both molecules might also contribute to favour the passage of penciclovir through the epidermis into the deeper basal cells. BioMed Central 2009-04-02 /pmc/articles/PMC2675515/ /pubmed/19341466 http://dx.doi.org/10.1186/1471-5945-9-3 Text en Copyright © 2009 Hasler-Nguyen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hasler-Nguyen, Nathalie
Shelton, Donald
Ponard, Gilbert
Bader, Marlene
Schaffrik, Martina
Mallefet, Pascal
Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
title Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
title_full Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
title_fullStr Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
title_full_unstemmed Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
title_short Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
title_sort evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675515/
https://www.ncbi.nlm.nih.gov/pubmed/19341466
http://dx.doi.org/10.1186/1471-5945-9-3
work_keys_str_mv AT haslernguyennathalie evaluationoftheinvitroskinpermeationofantiviraldrugsfrompenciclovir1creamandacyclovir5creamusedtotreatherpessimplexvirusinfection
AT sheltondonald evaluationoftheinvitroskinpermeationofantiviraldrugsfrompenciclovir1creamandacyclovir5creamusedtotreatherpessimplexvirusinfection
AT ponardgilbert evaluationoftheinvitroskinpermeationofantiviraldrugsfrompenciclovir1creamandacyclovir5creamusedtotreatherpessimplexvirusinfection
AT badermarlene evaluationoftheinvitroskinpermeationofantiviraldrugsfrompenciclovir1creamandacyclovir5creamusedtotreatherpessimplexvirusinfection
AT schaffrikmartina evaluationoftheinvitroskinpermeationofantiviraldrugsfrompenciclovir1creamandacyclovir5creamusedtotreatherpessimplexvirusinfection
AT mallefetpascal evaluationoftheinvitroskinpermeationofantiviraldrugsfrompenciclovir1creamandacyclovir5creamusedtotreatherpessimplexvirusinfection